View in EDS

Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.

Saved in:
Bibliographic Details
Title: Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.
Authors: Manza P; Kahlert Institute for Addiction Medicine, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Belcher AM; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Fitzsimons H; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Spaderna M; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Greenblatt AD; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Smith HC; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Derenoncourt M; Clinical Center, National Institutes of Health, Bethesda, MD, USA., Gann D; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Farooq U; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Kvarta MD; Maryland Psychiatric Research Center, Departments of Psychiatry and Physiology, University of Maryland Baltimore, Baltimore, MD, USA.; Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA., DiPaula BA; Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, MD, USA., Merritt S; Lifestream Health Center, Bowie, MD, USA., Mitic I; Baltimore Ketamine Clinic, Sparks, MD, USA., Zarate CA; Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA., Gould TD; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology University of Maryland Baltimore, Baltimore, MD, USA.; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA., Weintraub E; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA., Kattakuzhy SM; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology University of Maryland Baltimore, Baltimore, MD, USA.; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.; Division of Clinical Care and Research, Institute of Human Virology, Division of Infectious Disease, University of Maryland Baltimore, Baltimore, MD, USA.
Source: The American journal of drug and alcohol abuse [Am J Drug Alcohol Abuse] 2025; Vol. 51 (5), pp. 649-657. Date of Electronic Publication: 2025 Aug 22.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 7502510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-9891 (Electronic) Linking ISSN: 00952990 NLM ISO Abbreviation: Am J Drug Alcohol Abuse Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40844815
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Manza+P%22">Manza P</searchLink>; Kahlert Institute for Addiction Medicine, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Belcher+AM%22">Belcher AM</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fitzsimons+H%22">Fitzsimons H</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Spaderna+M%22">Spaderna M</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Greenblatt+AD%22">Greenblatt AD</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Smith+HC%22">Smith HC</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Derenoncourt+M%22">Derenoncourt M</searchLink>; Clinical Center, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gann+D%22">Gann D</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Farooq+U%22">Farooq U</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kvarta+MD%22">Kvarta MD</searchLink>; Maryland Psychiatric Research Center, Departments of Psychiatry and Physiology, University of Maryland Baltimore, Baltimore, MD, USA.; Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22DiPaula+BA%22">DiPaula BA</searchLink>; Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Merritt+S%22">Merritt S</searchLink>; Lifestream Health Center, Bowie, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mitic+I%22">Mitic I</searchLink>; Baltimore Ketamine Clinic, Sparks, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zarate+CA%22">Zarate CA</searchLink>; Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gould+TD%22">Gould TD</searchLink>; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology University of Maryland Baltimore, Baltimore, MD, USA.; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Weintraub+E%22">Weintraub E</searchLink>; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland Baltimore, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kattakuzhy+SM%22">Kattakuzhy SM</searchLink>; Departments of Psychiatry, Pharmacology, Anatomy & Neurobiology University of Maryland Baltimore, Baltimore, MD, USA.; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.; Division of Clinical Care and Research, Institute of Human Virology, Division of Infectious Disease, University of Maryland Baltimore, Baltimore, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227502510%22">The American journal of drug and alcohol abuse</searchLink> [Am J Drug Alcohol Abuse] 2025; Vol. 51 (5), pp. 649-657. <i>Date of Electronic Publication: </i>2025 Aug 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502510 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-9891 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200952990%22">00952990 </searchLink><i>NLM ISO Abbreviation: </i>Am J Drug Alcohol Abuse <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40844815
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/00952990.2025.2541212
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 649
    Titles:
      – TitleFull: Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Manza P
      – PersonEntity:
          Name:
            NameFull: Belcher AM
      – PersonEntity:
          Name:
            NameFull: Fitzsimons H
      – PersonEntity:
          Name:
            NameFull: Spaderna M
      – PersonEntity:
          Name:
            NameFull: Greenblatt AD
      – PersonEntity:
          Name:
            NameFull: Smith HC
      – PersonEntity:
          Name:
            NameFull: Derenoncourt M
      – PersonEntity:
          Name:
            NameFull: Gann D
      – PersonEntity:
          Name:
            NameFull: Farooq U
      – PersonEntity:
          Name:
            NameFull: Kvarta MD
      – PersonEntity:
          Name:
            NameFull: DiPaula BA
      – PersonEntity:
          Name:
            NameFull: Merritt S
      – PersonEntity:
          Name:
            NameFull: Mitic I
      – PersonEntity:
          Name:
            NameFull: Zarate CA
      – PersonEntity:
          Name:
            NameFull: Gould TD
      – PersonEntity:
          Name:
            NameFull: Weintraub E
      – PersonEntity:
          Name:
            NameFull: Kattakuzhy SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1097-9891
          Numbering:
            – Type: volume
              Value: 51
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: The American journal of drug and alcohol abuse
              Type: main
ResultId 1